List of Digital Health/Medicine Companies in Australia - 3

Atomo Diagnostics is a medical device manufacturer headquartered in Sydney, Australia with offices in South Africa and the United Kingdom. Atomo Diagnostics was established to capitalise on a core belief that healthcare products offering significantly improved levels of convenience, simplicity and user experience are disproportionately disruptive and have the potential to be very successful commercial market entrants. In 2013, Atomo introduced AtomoRapid, a range of safe, simple professional use tests that deliver fast and accurate results in both clinical and community settings. In 2014, AtomoRapid HIV won Best in Show at the Medical Device Excellence Awards (MDEA) and Atomo was named Australian Emerging Company of the Year for 2014 by Johnson & Johnson Innovation. Atomo is committed to increasing the early detection and ongoing treatment of infectious and chronic diseases by making testing safer, more accurate and more accessible. Visit our website, www.atomodiagnostics.com, for more information on our company and products.

Cardiex Limited (ASX:CDX) is a medical technology company listed on the ASX, focusing on non-invasive vascular health monitoring and digital biomarker solutions for cardiovascular disease management. The company specializes in technologies that measure arterial stiffness and central blood pressure, addressing global cardiovascular health challenges. Cardiex develops FDA-cleared medical devices and digital health solutions aimed at assessing cardiovascular risk, detecting early disease onset, and monitoring treatment efficacy. Its flagship product, the SphygmoCor® system, is recognized for measuring central aortic pressures and arterial stiffness. The company offers services such as clinical decision support, clinical trial solutions, remote patient monitoring, and research partnerships, targeting healthcare providers, clinical trials, researchers, and consumers. With a commitment to reducing the global burden of cardiovascular disease, Cardiex has seen significant revenue growth and has established partnerships to enhance wearable technology adoption. Its product lineup includes the CONNEQT Pulse, a connected vascular biometric monitor, and the Arty™ App for remote patient monitoring, among others.

Emyria Limited is a clinical services and drug development company focused on improving patient outcomes in neuroscience and mental health via a unique business model: Emyria Clinics: Deliver evidence-based and emerging therapies for mental health and other unmet needs across multiple sites. Emyria Data: Robust and ethically-sourced Real-World Data gathered with patients. Emyria Data is used to improve Emyria’s distinct therapy and drug development programs. Emyria Drug Discovery: One of the world's largest libraries of unique MDMA-like compounds developed in partnership with the University of Western Australia and a suite of high potency Ultra-Pure cannabinoids currently being evaluated as in clinical trials for a range of mental health and select neuroscience indications.